NCT04166318 2026-03-02
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
Clinical Trials
13 trialsNCT06640283 2025-12-24
ANA
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05040815 2025-10-02
INSPIRE
AHS Cancer Control Alberta
Phase 2 Recruiting
NCT00324415 2025-05-30
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
AIDS Malignancy Consortium
Phase 2 Completed
NCT02437851 2025-04-11
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
AIDS Malignancy Consortium
Phase 2 Active not recruiting
NCT03946358 2024-12-20
VolATIL
Centre Hospitalier Universitaire de Besancon
Phase 2 Completed
NCT02185443 2024-12-09
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
University of Sao Paulo
Phase 2 Recruiting
NCT05060471 2024-12-03
PD-1 Blockade Combined with Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients
Sun Yat-sen University
Phase 2 Completed
NCT00316888 2023-06-29
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT02560298 2023-06-22
InterAACT
Eastern Cooperative Oncology Group
Phase 2 Unknown
NCT02402842 2022-05-16
Epitopes-HPV02
Centre Hospitalier Universitaire de Besancon
Phase 2 Completed
NCT00754078 2016-07-06
A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy
AHS Cancer Control Alberta
Phase 2 Unknown
NCT01941966 2014-03-28
A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.
Instituto do Cancer do Estado de São Paulo
Phase 2 Completed